Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001021014-03-000001
Filing Date
2003-08-12
Accepted
2003-08-12 16:01:42
Documents
1
Period of Report
2003-08-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4688
  Complete submission text file 0001021014-03-000001.txt   6686
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address C/O GENZYME CORP ONE KENDALL SQ CAMBRIDGE MA 02139-1562 6172527500
COX GEOFFREY F (Reporting) CIK: 0001021014 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 03837674
SIC: 2836 Biological Products, (No Diagnostic Substances)